Then, using detailed clinical outcome measures and household-level mosquito data to control for heterogeneity in environmental exposure to infected mosquitos (15), we analyzed the relationship between these CD4 subsets and prospective protection from Pf infection, and (separately) risk of developing clinical malaria once infected. The gene discussed is CD4; the disease is malaria.